SARA GEASLIN: Open Payments
NPI 1730598186 · JOHNSON CITY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,589 in 69 payments from 17 companies in 2025. Trend: 2023 $363 · 2024 $88 · 2025 $1,589
Food & beverage: $1,589
| Company | Payments | Amount |
|---|---|---|
| CSL Behring | 13 | $282 |
| AstraZeneca Pharmaceuticals LP | 12 | $248 |
| GlaxoSmithKline, LLC. | 7 | $137 |
| Grifols USA, LLC | 6 | $116 |
| BioCryst US Sales Co., LLC | 4 | $106 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $103 |
| GENZYME CORPORATION | 3 | $95 |
| Regeneron Healthcare Solutions, Inc. | 3 | $92 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $87 |
| Cycle Pharmaceuticals Inc | 3 | $78 |
Products named: DUPIXENT, Hizentra, Xembify, Andembry, AIRSUPRA, ORLADEYO, NEFFY, FASENRA.
Industry payments across TN — which companies pay providers there.
